Uniphar’s acquisition of Irish-headquartered pharmacy solutions business NaviCorp is to be investigated by the Competition and Consumer Protection Commission .
The deals were expected to deliver a return on capital employed to the group in line with Uniphar’s target rate of 12-15 per cent within three years.
IrishTimes So what if the final incarnation refuses to deal with the government on pharmaceutical pricing?
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: businessposthq - 🏆 8. / 71 더 많은 것을 읽으십시오 »
출처: IrishTimesBiz - 🏆 6. / 77 더 많은 것을 읽으십시오 »